Wang Ging Kuo, Calderon Joanna, Wang Sho-Ya
Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Mol Pharmacol. 2008 Mar;73(3):940-8. doi: 10.1124/mol.107.041541. Epub 2007 Dec 13.
Ranolazine is an antianginal agent that targets a number of ion channels in the heart, including cardiac voltage-gated Na(+) channels. However, ranolazine block of muscle and neuronal Na(+) channel isoforms has not been examined. We compared the state- and use-dependent ranolazine block of Na(+) currents carried by muscle Nav1.4, cardiac Nav1.5, and neuronal Nav1.7 isoforms expressed in human embryonic kidney 293T cells. Resting and inactivated block of Na(+) channels by ranolazine were generally weak, with a 50% inhibitory concentration (IC(50)) >/= 60 microM. Use-dependent block of Na(+) channel isoforms by ranolazine during repetitive pulses (+50 mV/10 ms at 5 Hz) was strong at 100 microM, up to 77% peak current reduction for Nav1.4, 67% for Nav1.5, and 83% for Nav1.7. In addition, we found conspicuous time-dependent block of inactivation-deficient Nav1.4, Nav1.5, and Nav1.7 Na(+) currents by ranolazine with estimated IC(50) values of 2.4, 6.2, and 1.7 microM, respectively. On- and off-rates of ranolazine were 8.2 microM(-1) s(-1) and 22 s(-1), respectively, for Nav1.4 open channels and 7.1 microM(-1) s(-1) and 14 s(-1), respectively, for Nav1.7 counterparts. A F1579K mutation at the local anesthetic receptor of inactivation-deficient Nav1.4 Na(+) channels reduced the potency of ranolazine approximately 17-fold. We conclude that: 1) both muscle and neuronal Na(+) channels are as sensitive to ranolazine block as their cardiac counterparts; 2) at its therapeutic plasma concentrations, ranolazine interacts predominantly with the open but not resting or inactivated Na(+) channels; and 3) ranolazine block of open Na(+) channels is via the conserved local anesthetic receptor albeit with a relatively slow on-rate.
雷诺嗪是一种抗心绞痛药物,作用于心脏中的多种离子通道,包括心脏电压门控钠通道(Na(+)通道)。然而,雷诺嗪对肌肉和神经元钠通道亚型的阻滞作用尚未得到研究。我们比较了在人胚肾293T细胞中表达的肌肉型Nav1.4、心脏型Nav1.5和神经元型Nav1.7亚型所携带的钠电流在状态和使用依赖性方面的雷诺嗪阻滞情况。雷诺嗪对钠通道的静息和失活阻滞作用通常较弱,半数抑制浓度(IC(50))≥60 μM。在重复脉冲期间(5 Hz时+50 mV/10 ms),雷诺嗪对钠通道亚型的使用依赖性阻滞在100 μM时较强,Nav1.4的峰值电流降低高达77%,Nav1.5为67%,Nav1.7为83%。此外,我们发现雷诺嗪对失活缺陷型Nav1.4、Nav1.5和Nav1.7钠电流有明显的时间依赖性阻滞,估计IC(50)值分别为2.4、6.2和1.7 μM。对于Nav1.4开放通道,雷诺嗪的结合和解离速率分别为8.2 μM(-1) s(-1)和22 s(-1),对于Nav1.7对应通道分别为7.1 μM(-1) s(-1)和14 s(-1)。失活缺陷型Nav1.4钠通道的局部麻醉药受体处的F1579K突变使雷诺嗪的效力降低了约17倍。我们得出以下结论:1)肌肉和神经元钠通道对雷诺嗪阻滞的敏感性与心脏钠通道相当;2)在其治疗血浆浓度下,雷诺嗪主要与开放的而非静息或失活的钠通道相互作用;3)雷诺嗪对开放钠通道的阻滞是通过保守的局部麻醉药受体,尽管结合速率相对较慢。